Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,008 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Has recurrent brief depression a different pharmacology.
Montgomery D, Green M, Bullock T, Baldwin D, Montgomery SA. Montgomery D, et al. Among authors: montgomery sa. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:13A-14A. doi: 10.1097/00002826-199201001-00006. Clin Neuropharmacol. 1992. PMID: 1498780 No abstract available.
Features of recurrent brief depression.
Montgomery SA, Montgomery D. Montgomery SA, et al. Among authors: montgomery d. Encephale. 1992 Sep;18 Spec No 4:521-3. Encephale. 1992. PMID: 1308849
The nature and recurrence of RBD on placebo.
Bullock T, Montgomery D, Baldwin D, Green M, Montgomery SA. Bullock T, et al. Among authors: montgomery sa, montgomery d. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:11A-12A. doi: 10.1097/00002826-199201001-00005. Clin Neuropharmacol. 1992. PMID: 1498772 No abstract available.
Selective serotonin reuptake inhibitors in OCD.
Montgomery SA, Bullock T, Fineberg N, Montgomery D. Montgomery SA, et al. Among authors: montgomery d. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:255A-256A. doi: 10.1097/00002826-199201001-00133. Clin Neuropharmacol. 1992. PMID: 1498831 No abstract available.
5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
Baldwin D, Bullock T, Montgomery D, Montgomery S. Baldwin D, et al. Among authors: montgomery d, montgomery s. Int Clin Psychopharmacol. 1991 Dec;6 Suppl 3:49-55; discussion 55-6. doi: 10.1097/00004850-199112003-00005. Int Clin Psychopharmacol. 1991. PMID: 1839632 Review.
Plasma-level response relationships with fluoxetine and zimelidine.
Montgomery SA, Baldwin D, Shah A, Green M, Fineberg N, Montgomery D. Montgomery SA, et al. Among authors: montgomery d. Clin Neuropharmacol. 1990;13 Suppl 1:S71-5. doi: 10.1097/00002826-199001001-00008. Clin Neuropharmacol. 1990. PMID: 2143100
The duration, nature and recurrence rate of brief depressions.
Montgomery SA, Montgomery D, Baldwin D, Green M. Montgomery SA, et al. Among authors: montgomery d. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(5):729-35. doi: 10.1016/0278-5846(90)90043-g. Prog Neuropsychopharmacol Biol Psychiatry. 1990. PMID: 2293253 Clinical Trial.
Prophylactic treatment of depression: a public health issue.
Montgomery SA, Green M, Baldwin D, Montgomery D. Montgomery SA, et al. Among authors: montgomery d. Neuropsychobiology. 1989;22(4):214-9. doi: 10.1159/000118619. Neuropsychobiology. 1989. PMID: 2486381 Review.
Intermittent 3-day depressions and suicidal behaviour.
Montgomery SA, Montgomery D, Baldwin D, Green M. Montgomery SA, et al. Among authors: montgomery d. Neuropsychobiology. 1989;22(3):128-34. doi: 10.1159/000118606. Neuropsychobiology. 1989. PMID: 2485860
1,008 results